FDA approved the first new kind of pain medication in 27 years. Here’s how it works
The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...
clinicaladvisor.com10d
Astronauts Experience Acute and Chronic Pain During and After Spaceflight
Researchers assessed physiologic changes of the spine as well as the frequency of low back pain among astronauts during and after spaceflight.
Two biomarkers in the brain could transform how chronic pain is understood and managed
In an international effort, researchers at Western, the University of Maryland School of Dentistry (UMSOD) and Neuroscience ...
Healio7d
FDA approves nonopioid Journavx for moderate to severe acute pain
The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...
MedPage Today5d
Which Analgesic is Best for Acute Pediatric Pain?
Opens in a new tab or window NSAIDs, ketamine, and mid- to high-potency opioids reduced acute pediatric pain, but effects were modest NSAIDs provided the greatest benefit and the least harm ...
Medscape10d
Novel Brain Biomarker Accurately Predicts Pain Sensitivity
“We are currently undertaking studies to show the accuracy and reliability of using the biomarker in clinical populations (jaw and low back pain) to predict who will transition from acute to ...
FDA approves new type of non-opioid pain medication, 1st of its kind in more than 20 years
The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called Journavx (suzetrigine) ...
NBC News on MSN8d
FDA approves new type of nonopioid painkiller for acute pain
The drug, Journavx, or suzetrigine, was approved to treat moderate to severe acute, or short-term, pain in adults. Experts say the drug, which is billed as nonaddictive, could reduce the number of ...